- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04555330
Technology Assisted Physical Activity Among Hospitalised Medical Patients (TAPAS-2)
Research show that inactivity during hospitalization is the norm and that the negative effects on muscle mass and the fitness of the patient will take a long time and hard work to recover afterwards.
Especially for weaker elderly patients, just a few days in bed could mean that they are not able to take care of themselves afterwards, with increased care expenses and increased risk of relapse as a consequence. Even though this is known, the work to motivate patients to be active during their hospitalization is limited to few training sessions with only the most vulnerable patients. No tools are today available for objectively tracking and motivating patients to be active during their stay. Having such a professional tool would not only motivate but also shift the attention of the health professionals towards the importance of physical activity in the treatment of the patient.
The aim of the studys is to investigate if patients hospitalised for medical disease will increase their time spent out of bed during hospitalisation through simple visual feedback about physical activities from a mobile bedside device.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study will be conducted as a quasi-randomised trial using a large tertiary public hospital in Copenhagen, Denmark. Patients admitted to Department of Respiratory Medicine (2 wards), Department of Cardiology, and Department of Geriatrics will be included, and they will have their physical activity level measured either with or without a bedside monitor providing visual feedback of time spent bedridden, sitting, standing and walking.
All participants will have their physical activity measured during hospitalisation. Approximately half of the participants will receive visual feedback about the amount of physical activity from a mobile device placed on the bedside table.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Copenhagen, Denmark, 2400
- Bispebjerg Hospital, Department of Physical and Occupational Therapy
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
INCLUSION CRITERIA
An individual will be eligible for study participation if he/she meets the following criteria:
- Is admitted to one of the participating departments
- Has signed informed consent
- Reads and speaks Danish
EXCLUSION CRITERIA
An individual will be excluded from the study if he/she meets any of the following criteria:
- Any condition that, in the opinion of the investigator, makes the person unfit for participation
- Expected hospitalisation less than 24 hours
- Has no independent ambulatory abilities (e.g. wheel chair user)
- Needs personal assistance in body transfers and ambulation (Cumulated Ambulation Score 0, 1, 2, or 3)
- Has allergy towards band aid
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Visual Feedback
Participants in the intervention group will receive usual hospital care and be provided with a sensor collecting data on physical activity level during hospitalisation AND a monitor placed at their bedside that displays information about their physical activity level and motivation to move.
This information will be visible to the health personnel, the patients and visitors.
|
To assess physical activity two small tri-axial accelerometers embedded in medical Band-Aids will be used. The accelerometers are discretely worn on the lateral aspect of the thigh. The accelerometers sample accelerations continuously during hospitalisation and are connected wirelessly to a tablet that via an inbuilt algorithm classify the recordings as bedridden (lying down), sitting, standing, and walking.
The tablet will be placed on the patients bedside table and provides feedback on the amount of physical activity and motivational imagesand texts that will be visible for the patients, the health care staff and visitors.
|
Other: Control Group
The participants in the non-exposed cohort will receive usual hospital care and be provided with a sensor collecting data on activity level during hospitalisation.No feedback on physical activity is provided.
|
To assess physical activity two small tri-axial accelerometers embedded in medical Band-Aids will be used. The accelerometers are discretely worn on the lateral aspect of the thigh. The accelerometers sample accelerations continuously during hospitalisation and are connected wirelessly to a tablet that via an inbuilt algorithm classify the recordings as bedridden (lying down), sitting, standing, and walking. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Time spent out of bed measured in minutes related to the total accelerometer wear time (minutes).
Time Frame: Through hospital stay, on average between 1 and 7 days
|
Through hospital stay, on average between 1 and 7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time spent lying down, measured in minutes related to the total accelerometer wear time (minutes).
Time Frame: Through hospital stay, on average between 1 and 7 days
|
Through hospital stay, on average between 1 and 7 days
|
|
Time spent sitting measured in minutes related to the total accelerometer wear time (minutes).
Time Frame: Through hospital stay, on average between 1 and 7 days
|
Through hospital stay, on average between 1 and 7 days
|
|
Time spent standing measured in minutes related to the total accelerometer wear time (minutes).
Time Frame: Through hospital stay, on average between 1 and 7 days
|
Through hospital stay, on average between 1 and 7 days
|
|
Time spent walking measured in minutes related to the total accelerometer wear time (minutes).
Time Frame: Through hospital stay, on average between 1 and 7 days
|
Through hospital stay, on average between 1 and 7 days
|
|
Length of stay
Time Frame: Time from hospital admission to hospital discharge
|
Length of hospitalisation measured in days
|
Time from hospital admission to hospital discharge
|
Readmission to hospital
Time Frame: within 90 days
|
within 90 days
|
|
In-hospital fall incidents
Time Frame: Through hospital stay, on average between 1 and 7 days
|
Number of falls recorded
|
Through hospital stay, on average between 1 and 7 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FYS-2019-017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Disease
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Kırıkkale UniversityRecruitingCOPD (Chronic Obstructive Pulmonary Disease)Turkey
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPDNew Zealand
-
Astellas Pharma Global Development, Inc.CytokineticsCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
AstraZenecaParexel International Ltd; Cognizant Technology Solution; Center for Information... and other collaboratorsCompletedChronic Obstructive Pulmonary Disease COPDUnited States, Canada, France, Russian Federation, Ukraine, Hungary, Bulgaria
-
University of ZurichNational Center of Cardiology and Internal Medicine named after academician...CompletedChronic Obstructive Pulmonary Disease (COPD)Kyrgyzstan
Clinical Trials on Physical activity measurement
-
University of Eastern FinlandCompletedQuality of Life | Fatigue | Physical Activity | Relapsing Remitting Multiple SclerosisFinland
-
Marmara UniversityUnknown
-
Seoul National University HospitalCompletedWomen Who Underwent Midline Incision, Gynecological SurgeryKorea, Republic of
-
Marius HenriksenCompletedRespiratory DiseaseDenmark
-
Czech Technical University in PragueRecruitingBlood Pressure | Heart RateCzechia
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
Amsterdam UMC, location VUmcCompleted
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingSolid NeoplasmUnited States
-
Hacettepe UniversityEnrolling by invitation
-
Karamanoğlu Mehmetbey UniversityRecruitingWolff-Parkinson-White SyndromeTurkey